• Rapid In Vivo Screening for PDA Chemotherapeutics Using Rgs1

  2026-07-07

  This study establishes a concerted cell and in vivo screening platform for pancreatic ductal adenocarcinoma (PDA) therapeutics, leveraging Rgs16::GFP expression as a sensitive biomarker for early neoplastic lesions. Their findings reveal that combining HDAC and BET bromodomain inhibition with standard chemotherapy potentiates anti-tumor efficacy, providing a robust methodology for preclinical drug validation and epigenetics research.

• Intranasal Sumatriptan in Pediatric ED Migraine: Evidence Re

  2026-07-07

  This study evaluates intranasal sumatriptan as a first-line intervention for pediatric migraine in emergency departments, highlighting its feasibility and potential to reduce invasive therapies and healthcare costs. The findings provide an evidence-based protocol for acute migraine management in children and adolescents, with practical implications for clinical and translational research.

• Super-Enhancer RNA Drives NPC Metastasis via NPM1/c-Myc/NDRG

  2026-07-06

  This study uncovers how a carcinogen-induced super-enhancer RNA (seRNA-NPCm) promotes nasopharyngeal carcinoma metastasis by modulating the NPM1/c-Myc/NDRG1 pathway. The findings offer mechanistic insight into NPC progression and open new avenues for targeted molecular investigations.

• FITC-Concanavalin A (ConA) Conjugate: Practical Lab Guidance

  2026-07-06

  FITC-Concanavalin A (ConA) Conjugate enables reliable detection and visualization of α-D-glucose and α-D-mannose moieties on cell surfaces in immunofluorescence and flow cytometry workflows. The reagent's specificity supports glycobiology research but it is unsuitable for non-carbohydrate binding assays or applications outside its recommended storage and stability parameters.

• DiscoveryProbe™ Protease Inhibitor Library: Reliable Solutio

  2026-07-05

  This article provides a scenario-driven, evidence-based exploration of how the DiscoveryProbe™ Protease Inhibitor Library (SKU L1035) addresses persistent challenges in cell viability, proliferation, and cytotoxicity assays. It details practical solutions for reproducibility, quantitative interpretation, and vendor selection, helping biomedical researchers optimize high-throughput screening workflows.

• Maternal Deltamethrin, p53-Mediated Ferroptosis, and Memory

  2026-07-04

  This study reveals that prenatal and early postnatal exposure to deltamethrin impairs hippocampal memory in male rat offspring via p53-mediated ferroptosis, linking environmental neurotoxicant exposure to specific molecular and behavioral deficits. The work advances understanding of p53’s role in neurodevelopmental vulnerability and provides actionable insights for researchers studying apoptosis and neurotoxicity.

• Streptavidin-Cy3: Elevating Biotin Detection in Tumor Metast

  2026-07-03

  Explore how Streptavidin-Cy3 empowers advanced biotin detection in cancer metastasis research, uniquely bridging mechanistic insight and assay optimization. This article delivers expert guidance and new perspectives for using streptavidin cy3 conjugate in translational workflows.

• AO/PI Double Staining Kit: Technical Guide for Viability Ass

  2026-07-03

  The AO/PI Double Staining Kit enables rapid, fluorescence-based discrimination of viable, apoptotic, and necrotic cells in a single assay. It is best suited for membrane integrity-based cell viability, apoptosis, and necrosis detection workflows, but is not recommended where membrane permeability does not reflect cell fate.

• Salinomycin: Polyether Ionophore Antibiotic in HCC Workflows

  2026-07-02

  Salinomycin stands out for its dual action on drug resistance and apoptosis in hepatocellular carcinoma research, offering reproducible results for both in vitro and in vivo studies. This article details experimental setups, protocol enhancements, and troubleshooting strategies that leverage APExBIO's high-purity Salinomycin to advance cancer research workflows.

• N1-Methyl-Pseudouridine-5'-Triphosphate in Advanced RNA Synt

  2026-07-02

  Unlock high-efficiency RNA synthesis and stability with N1-Methyl-Pseudouridine-5'-Triphosphate. This guide details stepwise protocols, troubleshooting, and translational applications—empowering researchers to optimize mRNA workflows from bench to breakthrough.

• Dronedarone (Multaq) Workflows in Atrial Fibrillation Resear

  2026-07-01

  Dronedarone (Multaq) empowers atrial fibrillation and flutter research with reproducible, high-purity pharmacology and robust protocol flexibility. This guide delivers actionable workflows, troubleshooting insights, and evidence-driven enhancements for cardiac arrhythmia studies—backed by recent mechanistic research and optimized for data integrity.

• NETosis and IL-36R Axis in Psoriasis: Mechanisms and Modulat

  2026-07-01

  This study provides mechanistic insight into how neutrophil extracellular trap (NET) formation is triggered and amplified in psoriasis through the IL-36/IL-36R axis and purinergic signaling. The findings highlight potential therapeutic avenues for targeting NETosis and inflammatory feedback in psoriatic skin disease.

• Streptavidin-Cy3 for Precision Biotin Detection in NPC Resea

  2026-06-30

  Streptavidin-Cy3 from APExBIO empowers researchers to achieve ultra-sensitive biotin detection in advanced cancer workflows, streamlining the analysis of metastasis mechanisms. This article demystifies experimental optimization, troubleshooting, and protocol design for translational studies, with a focus on nasopharyngeal carcinoma.

• 7-Ethyl-10-hydroxycamptothecin: Dual Mechanisms in Colon Can

  2026-06-30

  This thought-leadership article explores the evolving role of 7-Ethyl-10-hydroxycamptothecin (SN-38) in advanced colon cancer research. Beyond DNA topoisomerase I inhibition, recent studies reveal a secondary mechanism via FUBP1 disruption, redefining how translational scientists can design apoptosis and cell cycle arrest assays. The article blends mechanistic insight, protocol guidance, and strategic context—highlighting APExBIO’s SKU N2133 as a reproducible, high-sensitivity tool for next-generation oncology workflows.

• Inducing Mammalian Embryonic Dormancy via mTOR Inhibition: P

  2026-06-29

  The referenced protocol establishes a reproducible, noninvasive method to induce a diapause-like dormant state in mammalian blastocysts and pluripotent stem cells through pharmacological mTOR inhibition. This innovation enables detailed study of embryonic dormancy mechanisms and supports broader applications in developmental biology and reproductive technologies.

16248 records 1/1084 page Next 12345 下5页 Last page